Local and Systemic Immunity against Respiratory Syncytial Virus Induced by a Novel Intranasal Vaccine. A Randomized, Double-Blind, Placebo-controlled Clinical Trial. (2019)

First Author: Ascough S
Attributed to:  Human infection challenge vaccine (HIC-vac) network funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201810-1921oc

PubMed Identifier: 30753101

Publication URI: http://europepmc.org/abstract/MED/30753101

Type: Journal Article/Review

Volume: 200

Parent Publication: American journal of respiratory and critical care medicine

Issue: 4

ISSN: 1073-449X